A prospective survey to compare the suitability profiles of over-the-counter ibuprofen and paracetamol use in a French general practitioner-controlled population

Clinical Drug Investigation

Volumn 26, Issue 10, 2006, Pages 575-581

  Pigeon, Pierre ^a   Robillard, Eric ^a   Clarke, Geoffrey D ^b   Burnett, Ian ^b  

^a A+A Healthcare Marketing Research   (France)

^b GLAXOSMITHKLINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

IBUPROFEN; NON PRESCRIPTION DRUG; PARACETAMOL;

ADULT; AGED; ARTICLE; CONSULTATION; CONTROL GROUP; CONTROLLED STUDY; DEMOGRAPHY; DRUG CONTRAINDICATION; DRUG LABELING; DRUG SCREENING; DRUG USE; DRUG UTILIZATION; FEMALE; GENERAL PRACTITIONER; GEOGRAPHY; HUMAN; INFORMATION PROCESSING; MALE; PATIENT; PHYSICIAN; PRIORITY JOURNAL; PROSPECTIVE STUDY;

ACETAMINOPHEN; ADOLESCENT; ADULT; AGED; DRUGS, NON-PRESCRIPTION; FEMALE; HUMANS; IBUPROFEN; MALE; MIDDLE AGED; NONPRESCRIPTION DRUGS; PHYSICIANS, FAMILY; PROSPECTIVE STUDIES;

EID: 33748793931     PISSN: 11732563     EISSN: 11732563     Source Type: Journal    
DOI: 10.2165/00044011-200626100-00004     Document Type: Article

References (15)

1. Abbott FV, Fraser MI. Use and abuse of over-the-counter analgesic agents. J Psychiatry Neurosci 1998 Jan; 23 (1): 13-34
2. Whelton A. Appropriate analgesia: an evidence-based evaluation of the role of acetaminophen in pain management. Am J Ther 2005 Jan; 12 (1): 43-5
3. Nikles CJ, Yelland M, Del MC, et al. The role of paracetamol in chronic pain: an evidence-based approach. Am J Ther 2005 Jan; 12 (1): 80-91
4. Lewis SC, Langman MJ, Laporte JR, et al. Dose-response relationships between individual nonaspirin nonsteroidal anti-inflammatory drugs (NANSAIDs) and serious upper gastrointestinal bleeding: a meta-analysis based on individual patient data. Br J Clin Pharmacol 2002; 54 (3): 320-6
5. Wilcox CM, Cryer B, Triadafilopoulos G. Patterns of use and public perception of over-the-counter pain relievers: focus on nonsteroidal antiinflammatory drugs. J Rheumatol 2005 Nov; 32 (11): 2218-24
6. Toes MJ, Jones AL, Prescott L. Drug interactions with paracetamol. Am J Ther 2005 Jan; 12 (1): 56-66
7. Moore N, Van Ganse E, Le Parc JM, et al. The PAIN study: Paracetamol, Aspirin and Ibuprofen New tolerability study. A large-scale, randomised clinical trial comparing the tolerability of aspirin, ibuprofen and paracetamol for short-term analgesia. Clin Drug Invest 1999; 18 (2): 89-98
8. Burnett I, Clarke G. Methodological bias in over-the-counter analgesic tolerability study [abstract AB0288]. Presented at European League Against Rheumatism (EULAR) Annual Scientific Conference 2002 Jun 12-15; Stockholm. Ann Rheum Dis 2002; 61 Suppl. 1: 420
9. Peterson G. Down-scheduling of ibuprofen: any decision should be based on solid evidence. Australian Pharmacist 2003; 22 (9): 688-91
10. Peterson GM. Selecting nonprescription analgesics. Am J Ther 2005 Jan; 12 (1): 67-79
11. Le Parc JM, Van Ganse E, Moore N, et al. Comparative tolerability of paracetamol, aspirin and ibuprofen for short-term analgesia in patients with musculoskeletal conditions: results in 4291 patients. Clin Rheumatol 2002 Feb; 21 (1): 28-31
12. Moore N, Le Parc JM, Van Ganse E, et al. Tolerability of ibuprofen, aspirin and paracetamol for the treatment of cold and flu symptoms and sore throat pain. Int J Clin Pract 2002 Dec; 56 (10): 732-4
13. Moore N, Charlesworth A, Van Ganse E, et al. Risk factors for adverse events in analgesic drug users: results from the PAIN study. Pharmacoepidemiol Drug Saf 2003 Oct; 12 (7): 601-10
14. Rampal P, Moore N, Van Ganse E, et al. Gastrointestinal tolerability of ibuprofen compared with paracetamol and aspirin at over-the-counter doses. J Int Med Res 2002 May; 30 (3): 301-8
15. Van Ganse E, Jones JK, Moore N, et al. A large simple clinical trial prototype for assessment of OTC drug effects using patient-reported data. Pharmacoepidemiol Drug Saf 2005;14 (4): 249-55